Model-Based Drug Development
Smarter Decisions, Better Returns in the New Health
Turning healthy ideas into healthy humans has become a complex equation in the face of spiraling costs and rising scrutiny. Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions that optimize resources and returns.
We know that selecting the right dose, population, study, and program design are some of the most significant challenges facing pharmaceutical companies today. Quintiles’ modeling and simulation solutions provide you with the expertise and resources to give your molecules, studies and overall portfolio the best chance of success.
Michael O’Kelly, Centre for Statistics in Drug Development and Innovation, explains how MBDD supports a new level of confidence in decision-making. Video Length: 1:50.
Unrivaled Innovation, Experience and Clinical Expertise
Along with decades of experience across all key therapeutic areas, our model-based drug development team combines unsurpassed clinical expertise with state-of-the-art computational capabilities and software your clinical trials need. We are committed to helping you:
- Select the most advantageous dose for safety and efficacy
- Mitigate clinical trial risk to achieve better outcomes
- Design more robust clinical development programs
- Better manage drug candidate portfolio risks
- Maximize return on investment (ROI)
Comprehensive Model-Based Drug Development Services
Population Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling and Simulation
Identify the concentration-response relationship to solve your dosing strategy.
Clinical Trial Simulation
Test various trial designs in silico before running the actual study to establish the most efficient and informative solution.
Decision / Scenario Analyses
Better predict the probabilities of success for a given compound or program design.
Portfolio Optimization
Improve your ROI and net present value against your competition through the selection of the most advantageous compound and program design.
